Shengshi Taikе partners with Yunxuan Pharmaceutical to broadly deploy CXCR4 antagonists.
Time:2020-04-16 17:16
Time:2019-11-14 17:17
Shengshi Taikang Secures Over 100 Million Yuan in A+ Round Funding Led by Hongtai
Time:2019-07-30 17:23
Time:2019-02-28 17:23
Time:2018-12-07 17:26
Time:2018-11-14 17:31
Time:2018-11-05 15:48